Beam stock forecast.

Nov 29, 2023 · According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. There are four main types of forecasting methods that financial analysts use to predict future revenues, expenses, and capital costs for a business. While there are a wide range of frequently used quantitative budget forecasting tools, in this article we focus on four main methods: (1) straight-line, (2) moving average, (3) simple linear ...Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.NEW YORK, February 15, 2023--Beam Suntory, a world leader in premium spirits, today announced 2022 full year results, with net sales up 10.5% year on year, representing 24% growth versus the pre ...Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...

Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Beam Therapeutics Inc Stock Price Forecast for 2025: February 2025: Open: 7.446: Close: 0.762: Min: 0.762: Max: 8.429: Change: -877.73 % Beam Therapeutics Inc Stock Price …

The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46. Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...

As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.EXAS Stock 12 Months Forecast. $95.46. (50.43% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $95.46 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 50.43% change from the last price of $63.46.The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion provision in the ‘Build Back Better’ bill to political pressure on automakers to commit to increased production with the goal of converting 40% of car sales to EVs by the end of this decade, it’s clear that under Biden, the government has the will to enforce a …Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price. Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time AI - C3.ai Inc stock quotes, company profile, news and forecasts from CNN Business.

Apr 20, 2023 · Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...

The stock of Beam Therapeutics (BEAM 5.31%), a clinical-stage genetic base-editing company, has shed 48% of its value relative to its 52-week high in recent weeks.

Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Get Beam Therapeutics Inc (BEAM.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an …Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...

Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.BEAM - Beam Therapeutics Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Analyst Forecast. According to 9 analysts, the average rating for BEAM stock is "Buy." The 12-month stock price forecast is $55.22, which is an increase of …Aug 26, 2023 · Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ... Find real-time SMG - Scotts Miracle-Gro Co stock quotes, company profile, news and forecasts from CNN Business.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

Infibeam Avenues share price was Rs 20.15 as on 01 Dec, 2023, 03:59 PM IST. Infibeam Avenues share price was up by 0.74% based on previous share price of Rs 20.4. Infibeam Avenues share price trend: Last 1 Month: Infibeam Avenues share price moved up by 6.33%.According to 3 stock analysts, the average 12-month stock price forecast for Beam Global stock is $26.67, which predicts an increase of 343.02%. The lowest target is $25 and the highest is $30. On average, analysts rate Beam Global stock as a strong buy.See Beam Therapeutics Inc. (BEAM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.The global welding market size was valued at USD 23.75 billion in 2022. The market is projected to grow from USD 24.73 billion in 2023 to USD 34.18 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. The welding industry has witnessed significant technological advancements in recent years, including the development of new ...Radio-frequency identification (RFID) uses electromagnetic fields to automatically identify and track tags attached to objects. An RFID system consists of a tiny radio transponder, a radio receiver and transmitter.When triggered by an electromagnetic interrogation pulse from a nearby RFID reader device, the tag transmits digital data, usually an identifying …Real Money Technical Analyst Bruce Kamich gives his updated 2023 market forecast Employees of theStreet are prohibited from trading individual securities. Here's how traders can play this biotech stock. The charts of the building materials ...Beam Therapeutics is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... We provide commentary based on historical data and analyst forecasts ...Find the latest Steel Dynamics, Inc. (STLD) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Average 51.83 75.87% Upside Low 19.00 -35.53% Downside High 95.00 222.36% Upside Broker Rating Beam Therapeutics Inc. currently has an average brokerage recommendation (ABR) of 1.86 on a scale of...

A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …

Find the latest Teladoc Health, Inc. (TDOC) stock quote, history, news and other vital information to help you with your stock trading and investing.The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.18/10/2023. IBA plans total system restoration on its first-ever proton therapy installation. Analytical report. Stock ION BEAM APPLICATIONS Common Stock BE0003766806 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.Find the latest Quantum-Si incorporated (QSI) stock quote, history, news and other vital information to help you with your stock trading and investing.As for the stock performance of Beam Therapeutics, on October 2nd, it opened at $24.05. Over the past 50 days, the stock has exhibited a moving average price of $25.47, while its 200-day moving average stands at $29.78. It is worth noting that BEAM’s fifty-two week low is reported to be $22.52, with a high point of $54.30 during the same period.Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...The Beam Global stock forecast is 20.479620872586 USD for 2024 November 26, Tuesday; and 123.436 USD for 2028 November 26, Sunday with technical analysis. Beam Global (BEEM) stock price prediction is 20.479620872586 USD.Jun 12, 2022 · Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ...

Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Nov 28, 2023 · Analyst Forecast. According to 2 analysts, the average rating for BEAT stock is "Strong Buy." The 12-month stock price forecast is $6.78, which is an increase of 361.22% from the latest price. BEAM : Suntory Holdings Completes Acquisition of Beam Inc. 2014: BU BEAM : Jim Beam To Host "Distillery Days" In Clermont 2014: PR Beam : Announces Intention to Delist and Deregister Common Stock, 8 5/8% Debentures Due 2021 and 7 …View the latest Beam Therapeutics Inc. (BEAM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Instagram:https://instagram. dal stock forecastaverage cost of a hospital stay per daynew perspective fund american fundsvolkswagen porsche BEEM | Complete Beam Global stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find real-time DOCU - DocuSign Inc stock quotes, company profile, news and forecasts from CNN Business. akko phone insurance bbb ratingbest aircraft renters insurance Open the BEAM Page at The Online Investor (in a new window) » List of Beverages & Wineries Mergers & Acquisitions in this Slideshow:. 10/3/2012: Acquirer: Crystal Rock Holdings, Inc. (CRVP) Acquiree: Frontenac Crystal Springs and Girard Water Company Merger/Acquisition details: details » 12/14/2012: Acquirer: Coca-Cola FEMSA (KOF) …Dec 1, 2023 · A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. dividend paying reits Real Money Technical Analyst Bruce Kamich gives his updated 2023 market forecast Employees of theStreet are prohibited from trading individual securities. Here's how traders can play this biotech stock. The charts of the building materials ...Future criteria checks 1/6. Beam Therapeutics's earnings are forecast to decline at 11.2% per annum while its annual revenue is expected to grow at 12.2% per year. EPS is expected to decline by 3.5% per annum. Return on equity is forecast to be -82.9% in 3 years.